Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers

被引:54
作者
Berg, C
Geipel, A
Kohl, T
Breuer, J
Germer, U
Krapp, M
Baschat, AA
Hansmann, M
Gembruch, U
机构
[1] Univ Bonn, Zentrum Geburtshilfe & Frauenheilkunde, Abt Geburtshilfe & Pranatale Med, Dept Obstet & Prenatal Med, D-53105 Bonn, Germany
[2] Univ Bonn, Dept Pediat Cardiol, D-53105 Bonn, Germany
[3] Univ Regensburg, Dept Prenatal Med, D-8400 Regensburg, Germany
[4] Univ Hosp Schleswig Holstein, Dept Prenatal Med, Lubeck, Germany
[5] Univ Hamburg, Dept Obstet & Fetal Med, Hamburg, Germany
[6] Univ Maryland, Sch Med, Dept Obstet & Gynecol, Ctr Adv Fetal Care, Baltimore, MD 21201 USA
关键词
antinuclear antibodies; cardiac defects; echocardiography; fetus; heart block; heterotaxy; isomerism; prenatal diagnosis;
D O I
10.1002/uog.1918
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objectives To assess the spectrum of anomalies associated with fetal heart block and to identify possible prognostic markers. Method Retrospective review of all cases of second- or third-degree heart block identified in two tertiary referral centers in Germany (Bonn and Lubeck) and one in the USA (Baltimore). Results Sixty fetuses with heart block were identified in the study period. Thirty-two had complex cardiac malformations, 31 of them associated with left isomerism. The outcomes of these fetuses were 22 terminations of pregnancy (TOP), three intrauterine fetal deaths (IUFD), three neonatal deaths (NND), two childhood deaths (CD) and there were two survivors. In 20 cases without complex cardiac malformations maternal antinuclear-antibodies were detected. Their outcomes were 2 TOP, 1 IUFD, 1 NND and 16 survived. The remaining eight cases had neither complex cardiac malformations nor associated maternal antibodies. Their outcomes were 1 TOP, 2 IUFD, 2 NND and 3 survived. After exclusion of terminated cases, hydrops as well as the presence of cardiac defects was significantly associated with nonsurvival (P < 0.01). The cardiothoracic circumference ratio was significantly higher in hydropic fetuses and significantly negatively correlated with survival in immune-mediated cases (P < 0.01). Atrial and ventricular frequencies and their evolution did not accurately predict fetal or neonatal outcome. Sympathomimetic treatment in seven cases was not associated with favorable fetal outcome in cases of hydrops or cardiac malformations. Conclusions The most important marker predicting adverse outcome in cases of heart block is fetal hydrops, followed by the association with complex cardiac malformations. Cases without cardiac malformations have a significantly better prognosis, especially in the absence of severe cardiomegaly. Copyright (c) 2005 ISUOG.
引用
收藏
页码:4 / 15
页数:12
相关论文
共 47 条
[2]  
Anandakumar C, 1996, OBSTET GYNECOL, V87, P835
[3]   Diagnosis of heterotaxy syndrome by fetal echocardiography [J].
Atkinson, DE ;
Drant, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (09) :1147-+
[4]   First-trimester fetal heart block:: a marker for cardiac anomaly [J].
Baschat, AA ;
Gembruch, U ;
Knöpfle, G ;
Hansmann, M .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1999, 14 (05) :311-314
[5]   EVOLUTION OF COMPLETE HEART-BLOCK IN A FETUS AND ITS PERINATAL MANAGEMENT [J].
BAXI, L ;
BIERMAN, F ;
URSELL, P .
AMERICAN JOURNAL OF PERINATOLOGY, 1987, 4 (04) :348-351
[6]   Prenatal diagnosis of cardiosplenic syndromes: a 10-year experience [J].
Berg, C ;
Geipel, A ;
Smrcek, J ;
Krapp, M ;
Germer, U ;
Kohl, T ;
Gembruch, U ;
Baschat, AA .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 22 (05) :451-459
[7]   Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies:: a prospective controlled study [J].
Brucato, A ;
Doria, A ;
Frassi, M ;
Castellino, G ;
Franceschini, F ;
Faden, D ;
Pisoni, MP ;
Solerte, L ;
Muscarà, M ;
Lojacono, A ;
Motta, M ;
Cavazzana, I ;
Ghirardello, A ;
Vescovi, F ;
Tombini, V ;
Cimaz, R ;
Gambari, P ;
Meroni, PL ;
Canesi, B ;
Tincani, A .
LUPUS, 2002, 11 (11) :716-721
[8]   Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry [J].
Buyon, JP ;
Hiebert, R ;
Copel, J ;
Craft, J ;
Friedman, D ;
Katholi, M ;
Lee, LA ;
Provost, TT ;
Reichlin, M ;
Rider, L ;
Rupel, A ;
Saleeb, S ;
Weston, WL ;
Skovron, ML .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (07) :1658-1666
[9]   INTRAUTERINE THERAPY FOR PRESUMPTIVE FETAL MYOCARDITIS WITH ACQUIRED HEART-BLOCK DUE TO SYSTEMIC LUPUS-ERYTHEMATOSUS - EXPERIENCE IN A MOTHER WITH A PREDOMINANCE OF SS-B (LA) ANTIBODIES [J].
BUYON, JP ;
SWERSKY, SH ;
FOX, HE ;
BIERMAN, FZ ;
WINCHESTER, RJ .
ARTHRITIS AND RHEUMATISM, 1987, 30 (01) :44-49
[10]   IN-UTERO IDENTIFICATION AND THERAPY OF CONGENITAL HEART-BLOCK [J].
BUYON, JP ;
WALTUCK, J ;
KLEINMAN, C ;
COPEL, J .
LUPUS, 1995, 4 (02) :116-121